New patent for Orexo Us drug ZUBSOLV

Drug patent lawsuits for ZUBSOLV.

Copyright ©
DrugPatentWatch. Originally released at
New patent for Orexo Us drug ZUBSOLVAnnual Drug Patent Expirations for ZUBSOLV

This drug has forty patent member of the family in twenty-eight nations.

The generic ingredient in ZUBSOLV is buprenorphine hydrochloride; naloxone hydrochloride. Extra information are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.

To learn more on how DrugPatentWatch can assist with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

ZUBSOLV drug cost trends.

Zubsolv is a drug marketed by Orexo Us Inc and is consisted of in one NDA. There are 5 patents protecting this drug and 4 Paragraph IV difficulties.

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright ©
DrugPatentWatch. Initially released at
New patent for Orexo Us drug ZUBSOLV

Share this:

Related

LinkedIn
Twitter
Facebook
Email